Hillsborough, NJ, United States of America

Indrajit Ghosh

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Indrajit Ghosh: Innovator in Pharmaceutical Compositions

Introduction

Indrajit Ghosh is a notable inventor based in Hillsborough, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work primarily focuses on innovative formulations that address various medical disorders.

Latest Patents

Ghosh's latest patents include formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide. These patents provide pharmaceutical compositions and dosage forms of this compound, or its pharmaceutically acceptable stereoisomers, tautomers, solid forms, polymorphs, salts, hydrates, clathrates, or solvates. The patents also detail methods for treating, managing, or preventing disorders that can be addressed by inhibiting the JNK pathway in mammals using these pharmaceutical compositions. Additionally, the patents include methods for preparing salts of the compound.

Career Highlights

Throughout his career, Indrajit Ghosh has worked with prominent companies in the pharmaceutical industry, including Signal Pharmaceuticals, Inc. and Celgene Corporation. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Some of Ghosh's notable coworkers include Daozhong Zou and Nathan Andrew Boersen. Their collaborative efforts have likely enhanced the research and development of the innovative formulations he has patented.

Conclusion

Indrajit Ghosh's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex biochemical pathways and the potential for new treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…